Skip to main content
Equibles
NTRA logo

NTRA · Natera, Inc. · Metrics

Track NTRA — free

Use NTRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NTRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$403.95 +2.58 (+0.64%) At close · Oct 23
Russell 1000 member Rebalance outlook locked
Market Cap
$58.23B
Shares
144.14M
Volume · Oct 23 1.1M Avg daily vol (3M) 1.48M

NTRA metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$403.95
Market cap
$58.23B

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
-2.1%
Price change (3M)
+54.2%
Price change (6M)
+98.3%
Price change (YTD)
+76.3%
Price change (1Y)
+107.2%
Trailing year
Price change (5Y)
+251.5%
52-week high
$425.64
52-week low
$182.65
Change from 52-week high
-5.1%
Change from 52-week low
+121.2%
Annualized volatility
48.4%
Annualized volatility (3M)
54.8%
Beta
1.2
RSI (14D)
57.2
Price vs SMA 50
+10.1%
Price vs SMA 200
+54.4%
Avg volume (3M)
1.48M
Relative volume
0.7
Average dollar volume
$524.91M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
144.14M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
21.1×
reciprocal yield 4.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
21.5×
reciprocal yield 4.6%
P / book
32.0
reciprocal yield 3.1%
FCF yield
0.1%
TTM · current market cap
Buyback yield
—
P / FCF
691.6
reciprocal yield 0.1%
P / operating cash flow
255.1
reciprocal yield 0.4%
Earnings yield
-0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
11.2×
reciprocal yield 8.9%
EV / revenue historical average (5Y)
7.9×
reciprocal yield 12.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-10.7%
Trailing 12 months
Net margin
-7.1%
Gross profit (TTM)
$169.04M
Operating profit (TTM)
−$289.67M
Net income (TTM)
−$192.35M
Trailing 12 months
Diluted EPS (TTM)
$-1.35
FCF margin
3.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$19.30
Gross profit per diluted share (TTM)
$2.21
Operating profit per diluted share (TTM)
$-2.07
EBITDA per diluted share (TTM)
$-1.69
Net income per diluted share (TTM)
$-1.37
Operating cash flow per diluted share (TTM)
$1.63
Free cash flow per diluted share (TTM)
$0.61
Capital expenditures per diluted share (TTM)
$1.02
R&D per diluted share (TTM)
$5.61
Stock compensation per diluted share (TTM)
$2.72
Book value per share
$12.26

Growth

11 metrics
Revenue growth YoY
+37.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.71B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.1%
Year over year · more shares
Revenue CAGR (3Y)
+41.1%
Revenue CAGR (5Y)
+42.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-10.6%
Return on assets
-7.2%
Debt / equity
0.0
Current ratio
3.0
EBITDA (TTM)
−$237.00M
Free cash flow (TTM)
$84.20M
Quick ratio
2.9
Interest coverage
-75.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.01B
Latest balance sheet
Cash & equivalents
$1.09B
Total assets
$2.66B
Total debt
$80.29M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$228.24M
Capital expenditures (TTM)
$144.04M
R&D (TTM)
$787.38M
SG&A (TTM)
$1.25B
Stock compensation (TTM)
$381.42M
R&D / revenue
29.1%
Stock compensation / revenue
14.1%

Ownership (13F)

9 metrics
13F filers
854
13F filer change QoQ
+85
Institutional ownership
96.8%
Conviction holders (share of 13F filers)
2.6%
Crowding (high-turnover and private-fund holders)
32.9%
Private-fund adviser ownership
28.2%
Active holders' share change QoQ
0.0%
Holder tenure
16.3
Price vs estimated holder cost
+81.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.5%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$106.42M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1604821 CUSIP 632307104 13F (30d) 206 filings 201 filers Visit website Investor relations